Frederic L. W. V. J. Schaper, MD, PhD; Janne Nordberg, MD; Alexander L. Cohen, MD, PhD; et al.
open access
JAMA Neurol. 2023;80(9):891-902. doi:10.1001/jamaneurol.2023.1988
This case-control study evaluates the locations of epilepsy-associated lesions with respect to specific brain regions and networks.
Christina S. Dintica, PhD; Amber Bahorik, PhD; Feng Xia, MPH; et al.
has audio
JAMA Neurol. 2023;80(9):903-909. doi:10.1001/jamaneurol.2023.2120
This cohort study determines whether there is a difference in dementia incidence among Veterans Health Administration enrollees by neighborhood disadvantage as assessed by the Area Deprivation Index.
-
Audio:
Dementia Risk and Disadvantaged Neighborhoods
Kartik D. Bhatia, MBBS, PhD; Samyami Chowdhury, MBChB; Ian Andrews, MBBS; et al.
JAMA Neurol. 2023;80(9):910-918. doi:10.1001/jamaneurol.2023.2303
This case-control study evaluates whether pediatric patients with acute large vessel occlusion (LVO) stroke who undergo thrombectomy have better clinical outcomes than matched patients managed conservatively.
Ruijia Chen, ScD; Marie-Laure Charpignon, MS; Rafeya V. Raquib, MS; et al.
open access
JAMA Neurol. 2023;80(9):919-928. doi:10.1001/jamaneurol.2023.2226
This cross-sectional study compares COVID-19 pandemic-era excess deaths associated with Alzheimer disease or related dementias between year 1 and year 2 overall and by age, sex, race and ethnicity, and place of death.
Skylar Walters, MS; Alex G. Contreras, BS; Jaclyn M. Eissman, BS; et al.
open access
JAMA Neurol. 2023;80(9):929-939. doi:10.1001/jamaneurol.2023.2169
This genetic association study analyzes data from 4 Alzheimer disease and cognitive aging cohorts to investigate whether sex and race modify associations of APOE ε4 and ε2 with cognition.
Vicky Chalos, MD, PhD; Esmee Venema, MD, PhD; Maxim J. H. L. Mulder, MD, PhD; et al.
JAMA Neurol. 2023;80(9):940-948. doi:10.1001/jamaneurol.2023.2392
This prognostic study investigates the effectiveness of a prognostic tool to predict the functional outcome of individual patients after endovascular treatment for ischemic stroke.
Holly Elser, MD, PhD; Erzsébet Horváth-Puhó, PhD; Jaimie L. Gradus, DMSc, DSc; et al.
JAMA Neurol. 2023;80(9):949-958. doi:10.1001/jamaneurol.2023.2309
This cohort study investigates the association of dementia with early-, middle-, and late-life depression in a Danish cohort.
Camilla Dyremose Cornwall, MD; Thomas Krøigård, MD, PhD; Joachim Sejr Skovbo Kristensen, MD; et al.
JAMA Neurol. 2023;80(9):959-968. doi:10.1001/jamaneurol.2023.2407
This study attempts to assess clinical characteristics, causes, outcomes, prognostic factors, and treatment approaches for patients with super-refractory status epilepticus.
Pontus Erickson, BSc; Joel Simrén, MD; Wagner S. Brum; et al.
open access
JAMA Neurol. 2023;80(9):969-979. doi:10.1001/jamaneurol.2023.2338
This cohort study assesses the memory clinic prevalence and prognosis of individuals with a β-amyloid–negative, tau-positive cerebrospinal fluid biomarker profile.
Shyam K. Akula, PhD; Allen Y. Chen, MD, PhD; Jennifer E. Neil, MS, CGC; et al.
open access
JAMA Neurol. 2023;80(9):980-988. doi:10.1001/jamaneurol.2023.2363
This genetic association study assesses germline genetic causes of polymicrogyria in a large cohort and considers novel polymicrogyria gene associations.